[1]
|
Freedman, B., Boriani, G., Glotzer, T.V., Healey, J.S., Kirchhof, P. and Potpara, T.S. (2017) Management of Atrial High-Rate Episodes Detected by Cardiac Implanted Electronic Devices. Nature Reviews Cardiology, 14, 701-714. https://doi.org/10.1038/nrcardio.2017.94
|
[2]
|
Chiti, A. and Orlandi, G. (2012) Subclinical Atrial Fibrillation and the Risk of Stroke. New England Journal of Medicine, 366, 1351-1353.
|
[3]
|
Bertaglia, E., Blank, B., Blomström-Lundqvist, C., Brandes, A., Cabanelas, N., et al. (2019) Atrial High-Rate Episodes: Prevalence, Stroke Risk, Implications for Management, and Clinical Gaps in Evidence. EP Europace, 21, 1459-1467. https://doi.org/10.1093/europace/euz172
|
[4]
|
Proietti, M., Romiti, G.F., Vitolo, M., Borgi, M., Rocco, A.D., Farcomeni, A., et al. (2022) Epidemiology of Subclinical Atrial Fibrillation in Patients with Cardiac Implantable Electronic Devices: A Systematic Review and Meta-Regression. European Journal of Internal Medicine, 103, 84-94. https://doi.org/10.1016/j.ejim.2022.06.023
|
[5]
|
Jiang, J., Mi, L., Chen, K., Hua, W., Su, Y., Xu, W., et al. (2024) Association of Device-Detected Atrial High-Rate Episodes with Long-Term Cardiovascular and All-Cause Mortality: A Cohort Study. Canadian Journal of Cardiology, 40, 598-607. https://doi.org/10.1016/j.cjca.2023.12.007
|
[6]
|
Allam, L.E., Moneim, Y.A., Eldamanhoury, H.M. and Eltoukhy, S.M.A. (2025) Effect of Atrial High-Rate Episodes (AHREs) on Functional Status and Quality of Life (QoL) in Heart Failure—Cardiac Resynchronization Therapy Population. The Egyptian Heart Journal, 77, Article No. 19. https://doi.org/10.1186/s43044-025-00613-7
|
[7]
|
Olsen, F.J., Diederichsen, S.Z., Jørgensen, P.G., Jensen, M.T., Dahl, A., Landler, N.E., et al. (2024) Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-Term Continuous Monitoring in Elderly High-Risk Individuals. Circulation: Cardiovascular Imaging, 17, e016197. https://doi.org/10.1161/circimaging.123.016197
|
[8]
|
Glotzer, T.V., Hellkamp, A.S., Zimmerman, J., Sweeney, M.O., Yee, R., Marinchak, R., et al. (2003) Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation, 107, 1614-1619. https://doi.org/10.1161/01.cir.0000057981.70380.45
|
[9]
|
Glotzer, T.V., Daoud, E.G., Wyse, D.G., Singer, D.E., Ezekowitz, M.D., Hilker, C., et al. (2009) The Relationship between Daily Atrial Tachyarrhythmia Burden from Implantable Device Diagnostics and Stroke Risk: The TRENDS Study. Circulation: Arrhythmia and Electrophysiology, 2, 474-480. https://doi.org/10.1161/circep.109.849638
|
[10]
|
Boriani, G., Glotzer, T.V., Santini, M., West, T.M., De Melis, M., Sepsi, M., et al. (2013) Device-Detected Atrial Fibrillation and Risk for Stroke: An Analysis of >10 000 Patients from the SOS AF Project (Stroke Prevention Strategies Based on Atrial Fibrillation Information from Implanted Devices). European Heart Journal, 35, 508-516. https://doi.org/10.1093/eurheartj/eht491
|
[11]
|
Van Gelder, I.C., Healey, J.S., Crijns, H.J.G.M., Wang, J., Hohnloser, S.H., Gold, M.R., et al. (2017) Duration of Device-Detected Subclinical Atrial Fibrillation and Occurrence of Stroke in ASSERT. European Heart Journal, 38, 1339-1344. https://doi.org/10.1093/eurheartj/ehx042
|
[12]
|
Healey, J.S., Alings, M., Ha, A., Leong-Sit, P., Birnie, D.H., de Graaf, J.J., et al. (2017) Subclinical Atrial Fibrillation in Older Patients. Circulation, 136, 1276-1283. https://doi.org/10.1161/circulationaha.117.028845
|
[13]
|
Svennberg, E., Friberg, L., Frykman, V., Al-Khalili, F., Engdahl, J. and Rosenqvist, M. (2021) Clinical Outcomes in Systematic Screening for Atrial Fibrillation (STROKESTOP): A Multicentre, Parallel Group, Unmasked, Randomised Controlled Trial. The Lancet, 398, 1498-1506. https://doi.org/10.1016/s0140-6736(21)01637-8
|
[14]
|
Diederichsen, S.Z., Haugan, K.J., Brandes, A., Lanng, M.B., Graff, C., Krieger, D., et al. (2019) Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders. Journal of the American College of Cardiology, 74, 2771-2781. https://doi.org/10.1016/j.jacc.2019.09.050
|
[15]
|
Wattanachayakul, P., Yanpiset, P., Kulthamrongsri, N., Prasitsumrit, V., Lo, K.B., Kewcharoen, J., et al. (2025) Prognostic Values of Atrial High-Rate Episodes on Mortality Risks in CIED Patients. Journal of Cardiology. https://doi.org/10.1016/j.jjcc.2025.02.010
|
[16]
|
Martin, D.T., Bersohn, M.M., Waldo, A.L., Wathen, M.S., Choucair, W.K., Lip, G.Y.H., et al. (2015) Randomized Trial of Atrial Arrhythmia Monitoring to Guide Anticoagulation in Patients with Implanted Defibrillator and Cardiac Resynchronization Devices. European Heart Journal, 36, 1660-1668. https://doi.org/10.1093/eurheartj/ehv115
|
[17]
|
Kirchhof, P., Toennis, T., Goette, A., Camm, A.J., Diener, H.C., Becher, N., et al. (2023) Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. New England Journal of Medicine, 389, 1167-1179. https://doi.org/10.1056/nejmoa2303062
|
[18]
|
Healey, J.S., Lopes, R.D., Granger, C.B., Alings, M., Rivard, L., McIntyre, W.F., et al. (2024) Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. New England Journal of Medicine, 390, 107-117. https://doi.org/10.1056/nejmoa2310234
|
[19]
|
Lopes, R.D., Granger, C.B., Wojdyla, D.M., McIntyre, W.F., Alings, M., Mani, T., et al. (2024) Apixaban vs Aspirin According to CHA(2)DS(2)-VASc Score in Subclinical Atrial Fibrillation: Insights from ARTESiA. Journal of the American College of Cardiology, 84, 354-364. https://doi.org/10.1016/j.jacc.2024.05.002
|
[20]
|
Shoamanesh, A., Field, T.S., Coutts, S.B., Sharma, M., Gladstone, D., Hart, R.G., et al. (2025) Apixaban versus Aspirin for Stroke Prevention in People with Subclinical Atrial Fibrillation and a History of Stroke or Transient Ischaemic Attack: Subgroup Analysis of the ARTESiA Randomised Controlled Trial. The Lancet Neurology, 24, 140-151. https://doi.org/10.1016/s1474-4422(24)00475-7
|
[21]
|
McIntyre, W.F., Benz, A.P., Becher, N., Healey, J.S., Granger, C.B., Rivard, L., et al. (2024) Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation, 149, 981-988. https://doi.org/10.1161/circulationaha.123.067512
|
[22]
|
Becher, N., Toennis, T., Bertaglia, E., Blomström-Lundqvist, C., Brandes, A., Cabanelas, N., et al. (2023) Anticoagulation with Edoxaban in Patients with Long Atrial High-Rate Episodes ≥ 24 H. European Heart Journal, 45, 837-849. https://doi.org/10.1093/eurheartj/ehad771
|
[23]
|
McIntyre, W.F., Benz, A.P., Healey, J.S., Connolly, S.J., Yang, M., Lee, S.F., et al. (2024) Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial. Circulation, 150, 1747-1755. https://doi.org/10.1161/circulationaha.124.069903
|